Veytics Intelligence
2026-09-30 · NASDAQ

Eastwood Bio-Medical Canada Inc. Q3 Sales Increase

(RTTNews) - Eastwood Bio-Medical Canada Inc. (EBM.V) reported Loss for third quarter of -C$0.067 million The company's bottom line came in at -C$0.067 million, or -C$0.01 per share. This compares with -C$0.057 million, or -C$0.01 per share, last year. The company's revenue for the period rose 19.2% to C$0.149 million from C$0.125 million last year. Eastwood Bio-Medical Canada Inc. earnings at a glance (GAAP) : -Earnings: -C$0.067 Mln. vs. -C$0.057 Mln. last year. -EPS: -C$0.01 vs. -C$0.01 last year. -Revenue: C$0.149 Mln vs. C$0.125 Mln last year. (RTTNews) - Eastwood Bio-Medical Canada Inc. (EBM.V) reported Loss for third quarter of -C$0.067 million The company's bottom line came in at -C$0.067 million, or -C$0.01 per share. This compares with -C$0.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.